Comparison of clopidogrel-based antiplatelet therapy versus warfarin as a secondary prevention strategy for AntiPhospholipid Syndrome-related STROKE (APS-STROKE): Rationale and design of a prospective, randomized, open-label, blinded-endpoint trial
Wookjin Yang, Hee-Kwon Park, Seong‐Ho Koh, Seongheon Kim, Yerim Kim, Keun‐Hwa Jung, Hyun Goo Kang, Jay Chol Choi, Hahn Young Kim, Hyo Suk Nam, Hye Seon Jeong, Joon‐Tae Kim, Young Seo Kim, Sungwook Yu, Kyung‐Hee Cho, Tae‐Jin Song, Sung Hyuk Heo, Han‐Jin Cho, Sung‐Il Sohn, Yoonkyung Chang, Jong‐Moo Park, Mi Sun Oh, Eung‐Gyu Kim, Dong‐Ick Shin, Chulho Kim, Jun Lee, Seong Hwan Ahn, Yeong‐Bae Lee, Jong Wook Shin, Beom Joon Kim, Bum Joon Kim, Kwang‐Yeol Park, Hyung‐Min Kwon, Hyemin Jang, Jeong‐Min Kim, Jinkwon Kim, Seung‐Hoon Lee
IF 1.9 (2025) Contemporary Clinical Trials